Document is current
Any future updates will be listed below
-
Authors
van den Berg, K.
Schaap, D. P.
Voogt, E. L. K.
Buffart, T. E.
Verheul, H. M. W.
de Groot, J. W. B.
Verhoef, C.
Melenhorst, J.
Roodhart, J. M. L.
de Wilt, J. H. W.
van Westreenen, H. L.
Aalbers, A. G. J.
van ‘t Veer, M.
Marijnen, C. A. M.
Vincent, J.
Simkens, L. H. J.
Peters, N. A. J. B.
Berbée, M.
Werter, I. M.
Snaebjornsson, P.
Peulen, H. M. U.
van Lijnschoten, I. G.
Roef, M. J.
Nieuwenhuijzen, G. A. P.
Bloemen, J. G.
Willems, J. M. W. E.
Creemers, G. J. M.
Nederend, J.
Rutten, H. J. T.
Burger, J. W. A.
-
Funding
Funding for this research was provided by:
ZonMw (10070012010003)
- License Information
-
More Information
Article History
Received: 7 June 2022
Accepted: 29 July 2022
First Online: 6 September 2022
Declarations
:
: This study was approved by the Dutch competent authority (CCMO, The Hague, the Netherlands) and the Medical Research Ethics Committees United (MEC-U, Nieuwegein, the Netherlands). The reference number is R20.106. The study will be submitted to all institutional review boards to obtain approval prior to the start of the trial in the participating centres. Information regarding the study will be provided by the treating physician, a research nurse or a local investigator. A written informed consent is required of all study participants before inclusion in the study. Separate informed consent can be provided for the collection of blood and/or tissue for translational research and for quality of life questionnaires.
: This trial protocol does not contain any individual person’s data.
: The authors declare no competing interests.
